Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global macular degeneration treatment market reached a value of US$ 8.33 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 12.5 Billion by 2027 exhibiting a growth rate (CAGR) of 6.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Macular Degeneration Treatment Market Trends:

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, stage of disease, route of administration and end user.

Breakup by Type:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration
     

Breakup by Stage of Disease:

  • Early Stage
  • Intermediate Stage
  • Late Stage
     

Breakup by Route of Administration:

  • Intravenous Route
  • Intravitreal Route
     

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Stage of Disease, Route of Administration, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Macular Degeneration Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Dry Age-related Macular Degeneration
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Wet Age-related Macular Degeneration
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Stage of Disease
    7.1    Early Stage 
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Intermediate Stage 
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Late Stage 
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Route of Administration
    8.1    Intravenous Route
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Intravitreal Route
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Ambulatory Surgical Center
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Aerie Pharmaceuticals Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bausch Health Companies Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer AG
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche Ltd
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Iveric Bio Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Novartis AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Panoptica
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Pfizer Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Phio Pharmaceuticals
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
        15.3.10    Regeneron Pharmaceuticals Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Regenxbio Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Santen Pharmaceutical Co. Ltd.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2021
Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2021
Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2021
Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2021
Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2021
Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2021
Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2022-2027
Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
Table 8: Global: Macular Degeneration Treatment Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global macular degeneration treatment market was valued at US$ 8.33 Billion in 2021.

We expect the global macular degeneration treatment market to exhibit a CAGR of 6.70% during 2022-2027.

The rising incidences of age-related macular degeneration and obesity, along with the increasing adoption of macular degeneration treatment in enhancing vision and minimizing the risks of developing chronic blindness, are primarily driving the global macular degeneration treatment market.

The sudden outbreak of the COVID-19 pandemic had led to postponement of elective treatment for neurodegenerative ocular disorder to reduce the risk of coronavirus infection upon hospital visits or interaction with healthcare professionals.

Based on the type, the global macular degeneration treatment market has been segmented into dry age-related macular degeneration and wet age-related macular degeneration. Currently, wet age-related macular degeneration holds the majority of the total market share.

Based on the stage of disease, the global macular degeneration treatment market can be divided into early stage, intermediate stage, and late stage. Among these, late stage currently exhibits a clear dominance in the market.

Based on the route of administration, the global macular degeneration treatment market has been categorized into intravenous route and intravitreal route, where intravitreal route accounts for the largest market share.

Based on the end user, the global macular degeneration treatment market can be segregated into hospitals, ambulatory surgical center, and others. Currently, hospitals hold the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global macular degeneration treatment market include Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc., and Santen Pharmaceutical Co. Ltd.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links